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 ABSTRACT 
 
 
 
 
 
JUSTIN B. DAVIS 
Examining Disparities Related to the Use of Hospice Care: Cancer vs. Non-cancer 
Diagnoses 
(Under the direction of BRUCE C. PERRY, MD, MPH) 
 
 
 Americans often face end-of-life with ineffective pain/symptom control.  While 
hospice care prevents suffering for the terminally ill, only around 40% of individuals 
access services.  Although few studies describe differences in terms of cancer vs. non-
cancer diagnoses, hospice utilization/access disparities appear to exist.  Analyzing 14 
sociodemographic and clinical variables for 3,905 hospice discharge cases, this study 
highlights observed disproportions between cancer and non-cancer groups, identifying 
significant relationships amongst patient characteristics and hospice diagnosis.  Factors 
found significantly related to diagnosis include components of the following: age, 
primary payment source, mortality status at discharge, hospice initiation location, length 
of stay, physical function, cognitive function, and presence of pain symptoms.  Results 
confirm low overall hospice utilization rates, while validating diagnosis-specific 
differences driven by individual and population-based characteristics.  In order to 
increase utilization/access rates and eliminate current disparities, patients presenting with 
certain terminal diseases may require greater provider flexibility in terms of hospice 
eligibility requirements. 
 
 
INDEX WORDS: hospice care, palliative care, health disparities, cancer, chronic disease, 
death and dying, end-of-life
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Chapter I 
Introduction 
 
 
1.1 Background 
 Over at least the past six decades, the world’s human population has significantly 
transformed, experiencing record-breaking growth rates.  In addition to birthrate 
increases partially responsible for progress during the 20th century, the human lifespan 
also continues to lengthen, further compounding the rise in population and leading to 
momentous advances in aging (Schoeni & Ofstedal, 2010).  Evidence of the aging 
population includes not only longer life expectancies, but also the increase in the 
proportion of the elderly in today’s society.  Particularly, in the United States (U.S.), the 
percentage of individuals aged 65 and older is expected to comprise 20% of the total 
population by mid-21st century – a notable difference from roughly 4% in the early 
1900’s (McLaughlin, Connell, Heeringa, Li, & Roberts, 2010).   
 Paralleled by the evolving aging structure in the U.S., the conditions associated 
with living longer, along with the end-of-life experience, have also changed considerably 
in the past 100 years.  Due to advances in the fight against infectious disease, coupled 
with lower mortality rates, aging Americans now suffer from mostly lingering chronic 
conditions (Lehning & Austin, 2010).  Consequently, ailments such as heart, pulmonary, 
and cerebrovascular diseases currently prevail as leading causes of death (Mokdad, 
Marks, Stroup, & Gerberding, 2004).  Related primarily to the long-term nature of 
chronic diseases and the uncertainty regarding the multiple paths of decline that often 
lead to death, anticipating and approaching end-of-life issues and planning has 
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become increasingly challenging (Batchelor, 2010).  Certainly, Americans’ tendency to 
avoid the topic of death also complicates the ability and willingness to address such 
sensitive issues (Wasserman, 2008).   
 Although evidence-based models providing quality end-of-life care exist, a 
shocking proportion of Americans currently face death in undesirable settings, increasing 
their chances of experiencing inadequate pain and symptom control (Galanos, Morris, 
Pieper, Poppe-Ries, & Steinhauser, 2012).  Offering holistic care for those who are 
terminally ill, hospice services are generally regarded as superior in promoting comfort 
and quality of life; however, more than half of dying Americans lack the benefits that 
hospice provides (“NHPCO Facts,” 2012).  Furthermore, of those in the minority that do 
access hospice care at the end-of-life, most are referred too late in the disease process, as 
approximately 62% of hospice patients only receive 30 days or less of the potential 180+ 
days of care available (“NHPCO Facts,” 2012).  While the U.S. significantly outspends 
other developed nations in terms of medical advancement, unfortunately, most Americans 
suffer at end-of-life with underfunded care and low quality-of-death ratings (Hoefler, 
2010). 
 
1.2 Purpose of Study 
 Although commonly indicated by public health efforts, the promotion of health 
does not always involve prolonging life.  According to the World Health Organization, 
“Health is a state of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity” (“Preamble to the Constitution,” 1946).  Fittingly, when 
a disease process can no longer be prevented or reversed, well-being should translate to 
the absence of pain and suffering and overall quality of life remaining.  However, 
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previous research has shown that the American health care system is flawed in regards to 
the promotion of well-being at end-of-life (Bern-Klug, 2009; O’Mahony et al., 2008; 
Resnick, Foster, & Hickman, 2009; Walling et al., 2010).  While the hospice model of 
care remains backed by a considerable evidence base regarding efficacy, particularly in 
response to holistic well-being, a shocking majority of the U.S. population continues to 
face death without its benefits (“NHPCO Facts,” 2012).   
 Attempting to pinpoint answers concerning low hospice enrollment rates, 
numerous studies have indicated that significant disparities related to hospice access and 
utilization exist (Carrion, Park, & Lee, 2011; duPreez et al., 2008; Givens, Tjia, Zhou, 
Emanuel, & Ash, 2010; Silveira, Connor, Goold, McMahon, & Feudtner, 2011).  
However, since hospice was originally introduced as care for terminally ill cancer 
patients, much of the available research does not include cases with non-cancer diagnoses 
(Cohen, 2008).  Of the studies that do include the latter, most seem to focus on one 
particular disease (duPreez et al., 2008; Givens et al., 2010).  Consequently, relatively 
few studies attempt to describe hospice use disparities between general cancer and non-
cancer diagnosis groups, which remains concerning given the fact that the majority of 
hospice patients no longer suffer from cancer (“NHPCO Facts,” 2012).  By further 
expanding knowledge regarding hospice use disparities, a better understanding of 
methods to reach greater proportions of the American population with critical end-of-life 
services will emerge.  Likewise, the emergence of new knowledge creates the potential to 
improve care for those individuals who are already likely to access hospice services.  
Therefore, the purpose of this study is to describe hospice use statistics from a nationally 
representative sample of cancer and non-cancer hospice discharges, as well as explore the 
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relationship between diagnosis and patient/population characteristics in an attempt to 
illuminate factors that may play a role in imbalanced hospice utilization and access rates 
in the U.S. 
 
1.3 Research Questions 
 1. What are characteristics (sociodemographic and clinical) of a nationally    
      representative sample of hospice patients? 
 2. What are differences between patients with cancer vs. non-cancer hospice   
      diagnoses? 
 3. To what extent do patient/population characteristics (sociodemographic and    
      clinical) relate to hospice diagnosis? 
	  5 
Chapter II 
Review of Literature 
 
 
2.1 Aging 
     2.1.1 Aging Global Population 
 The 20th century brought about unprecedented growth in the world’s population.  
In the 18 years after World War II alone, the baby boomer generation multiplied, creating 
around 400 million new human lives (Olshansky, Goldman, Zheng, & Rowe, 2009).  
While many factors contributed to the dramatic increase in population, rises in fertility 
and improvements in mortality played large roles (Cherlin, 2010).  In particular, 
successes in infectious disease control and management of chronic disease have 
significantly affected lifespan (Schoeni & Ofstedal, 2010).  For example, those born in 
2010 will live around 17 years longer than their elders of 50 years, enjoying an average 
estimated lifespan of 69 years, worldwide (Schoeni & Ofstedal, 2010).  The success of 
aging is evident, especially when examining the world’s older population, aged 65 years 
plus (65+).  Between 2008 and 2040, it is estimated that this group will almost double in 
size, from 7.8% to 14.7% of the total population, which will equal around 1.3 billion 
older people by 2040 (Schoeni & Ofstedal, 2010).  Additionally, the world’s oldest-old 
population continues to increase.  Growing more quickly than the 65+ age group, the 
subset aged 80 plus (80+) is expected to represent 24% of the older population by 2040 
(Schoeni & Ofstedal, 2010).
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     2.1.2 Aging U.S. Population 
 Although developed countries are aging at slower rates than those in the 
developing world, the U.S. continues to experience significant growth (Schoeni & 
Ofstedal, 2010).  As with the world population, the U.S. also benefits from both increased 
longevity and decreased mortality.  The Social Security Administration estimates that 
overall morality will decline until 2032 by .86% per year (Olshansky et al., 2009).  The 
reduction in death rates leads to estimates of average life expectancy at birth ranging 
from 80.9 to 85.9 years for males and 85.3 to 93.3 for females by the year 2050 
(Olshansky et al., 2009).  Combining the effects of increased life expectancy and 
decreased mortality, there exists evidence that entire U.S. population will increase from 
304.2 million in 2008 to between 410 and 439 million by 2050 (Olshansky et al., 2009).  
Much of the overall estimated U.S. population growth is attributed to the increasing 
proportion of the old, those aged 65+.  Estimated to rise to 20% of the total population by 
2050, this group will have grown from a mere 4% at the beginning of the 20th century 
(McLaughlin et al., 2010).  The 16% increase in growth means that around 84 million 
Americans will comprise the 65+ population (Baernholdt, Hinton, Yan, Rose, & Mattos, 
2012).  Within the 65+ age group, the proportion of Americans reaching advanced old 
age has also become more commonplace, further contributing to the overall U.S. 
population growth rate.  Of those men and women born in 1900 who lived until at least 
65 years of age, 41% and 62% also reached age 80, respectively (Ailshire, Beltrán-
Sánchez, & Crimmins, 2011).  Of the approximately 84 million Americans estimated to 
be age 65+ by 2050, nearly 21 million will be over the age of 85 (Baernholdt et al., 
2012).  Considering that only 5.4 million Americans were 85 years or older in 2008, it is 
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apparent that great strides in aging are expected to continue (Olshansky et al., 2009).  
Looking at subsets of Americans within the 65+ age group, racial and ethnic minority 
populations are also expected to grow, increasing from 16.4% of the elderly in 2000 to 
25.4% by 2050 (Trask, Hepp, Settles, & Shabo, 2009).  Comparing 2000 statistics to 
2050 estimates, White individuals will decrease from representing 84% of the 65+ 
population to 64%, while African American individuals will increase from 8% to 12%, 
Asian individuals will increase from 2% to 7%, and Hispanic individuals will increase 
from 6% to 16% (Trask et al., 2009).  Although minority elder populations are expected 
to grow, inequalities in aging are still evident.  For instance, in 2002, life expectancy for 
African Americans and Whites differed by almost six years, with an expected lifespan of 
72.3 and 77.7 years, respectively (Weaver & Rivello, 2006). 
 
     2.1.3 Conditions of Aging in U.S. 
 As the U.S. elderly population continues to grow, much concern is being directed 
toward the fulfillment of living longer healthier, happier lives.  One of the leading 
concepts in the field involves the notion of successful aging, which includes components 
such as avoiding disease and disability, maintaining high levels of physical and cognitive 
function, and staying involved in social activities (Hank, 2011).  A recent study reports 
that as of 2004, only about 11% of Americans age 65+ meet the criteria of successful 
aging.  Furthermore, the prevalence of successful aging has shown decline since 1998, 
according to their analysis (McLaughlin et al., 2010).  Much of the disease faced by the 
older U.S. population consists of lingering chronic conditions.  As of 2009, statistics 
provide that 80% of adults over age 50 suffer from at least one chronic diagnosis 
(Lehning & Austin, 2010).  In addition to chronic disease, many older Americans also 
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face the risk of generally limiting conditions.  Research shows that in 2005, 40% of older 
adults lived with some type of disability (Lehning & Austin, 2010).  Moreover, in 2006, 
studies suggest that 20% of older adults were disabled due to chronic disease alone 
(McLaughlin et al., 2010).  Higher levels of chronic conditions and disability create 
extreme difficulties in maintaining physical function.  Assessment of functioning often 
involves an individual’s ability to engage in activities of daily living (ADL’s), such as 
eating, toileting, dressing, bathing, and walking (Berlau, Corrada, & Kawas, 2009).  By 
age 90, up to 51% of elders have been shown to struggle with five or six ADL’s, with 
28% completely relying on others for help when performing such activities (Berlau et al., 
2009).  Existing with the alarmingly low successful aging rates in the U.S. are disparities 
that remain disconcerting.  For example, individuals with lower incomes are 62% more 
likely to face moderate to severe disability than those with higher incomes (Huguet, 
Kaplan, & Feeny, 2008).  Additionally, studies report that aging White individuals tend 
to maintain better physical health and cognitive function than aging African Americans 
(Ailshire et al., 2011).  Generally, it appears that the odds of aging successfully are higher 
for White individuals, those with higher socioeconomic status (SES), and women 
(McLaughlin et al., 2010). 
 
2.2 Death and Dying in the U.S 
     2.2.1 Mortality 
 Over the past 40 years, the U.S. has experienced a significant decline in overall 
death rates.  Compared to the 1,242 per 100,000 age-standardized death rate in 1970, 
there was a 32% decrease by 2002, resulting in a 845 per 100,000 age-standardized death 
rate (Jemal, Ward, Hao, & Thun, 2005).  As of 2000, the leading causes of death were 
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heart disease, malignant neoplasms, cerebrovascular diseases, chronic lower respiratory 
disease, and unintentional injuries (Mokdad et al., 2004).  It is important to note, 
however, the underlying leading actual causes of death: tobacco, poor diet and physical 
inactivity, alcohol consumption, microbial agents, and toxic agents (Mokdad et al., 2004).  
Related primarily to changes in lifestyle associated with chronic illness, studies suggest 
that around 50% of deaths that year may have been preventable (Mokdad et al., 2004).  
From 1990 to 2000, deaths attributable to smoking increased almost 9%, while deaths 
attributable to diet and inactivity increased by 33%, and deaths attributable to alcohol 
consumption decreased by almost 18% (Mokdad et al., 2004).  Such staggering statistics 
highlight the influence of behavior on overall mortality.  Although death rates have 
declined, certain factors have been linked to increased mortality, particularly race and 
ethnicity.  For example, data shows that throughout the 20th century there was an African 
American-White male mortality difference of around 17-18% (Sloan, Ayyagari, Salm, & 
Grossman, 2010).  Additionally, as evidenced by 2002 data, the age-adjusted mortality 
rate for Whites was 829, as opposed to 1083.3 for African Americans (Weaver & Rivello, 
2006).  Also closely related to race and ethnicity, death rates by cause differ between 
populations.  In 2002, African Americans and Whites were similar in regards to the 
ranking of the top three leading causes of death (heart disease, malignant neoplasms, and 
cerebrovascular disease); however, diabetes mellitus ranked fourth for African 
Americans, instead of chronic lower respiratory disease (Weaver & Rivello, 2006).  
Compared to both African Americans and Whites in the same year, Hispanic or Latino, 
Asian or Pacific Islander, and American Indian or Alaska Native populations all 
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experienced lower overall mortality rates, at 629.3, 474.4, and 677.4, respectively 
(Weaver & Rivello, 2006).   
 In addition to race, SES and sex have also been shown to play a major role in 
disparities related to mortality.  For instance, 2001 data illustrates that African American 
males with less than 12 years of education have an age-standardized death rate of 1211, 
while African American males with greater than 16 years of education are affected by a 
lower rate of 386.5 (Jemal et al., 2008).  African American females in the same education 
scenario experience death rates of 577.6 versus 318.7 (Jemal et al., 2008).  
Correspondingly, inequalities connected to mortality and both sex and education hold 
true for the White population, albeit at lower rates than in the African American 
population.  White males with less than 12 years versus those with more than 16 years of 
education experience mortality rates of 914.6 and 216.2, while White females experience 
rates of 539.5 and 147.4, in the same situation (Jemal et al., 2008).  Ultimately, evidence 
suggests that each year the following populations experience more deaths than their 
counterparts: men, African Americans, and individuals having lower SES. 
 
     2.2.2 Onset of Death 
 Unfortunately, in the U.S., death largely remains a taboo topic.  Research 
documents that death is not only feared by Americans, but that both historic and current 
cultures support the denial of death (Wasserman, 2008).  Furthermore, academics submit 
that medical and pharmacological technologies have played a large role in attempts to 
postpone and renounce death; however, at some point, death becomes unavoidable (Bern-
Klug, 2009).  With the rise in chronic disease-related deaths, assessing approaching death 
and end-of-life matters proves increasingly difficult.  One popular concept addressing 
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such challenges is the “ambiguous dying syndrome”, which clearly identifies social and 
medical factors related to the health status of patients who are healthy or compromised 
versus those who are terminally ill (Bern-Klug, 2004).  The difficulty arises when 
considering patients who fall in the middle of the spectrum, the severely compromised –  
those experiencing conditions that are not quite recoverable or in the earliest stages, but 
at the same time, are not in advanced or final stages (Bern-Klug, 2004).   Data shows that 
around 60% of contemporary deaths may involve levels of ambiguity, creating confusion 
related to the appropriate medical approach, expectation of death, expectation of 
recovery, and patient’s social role (Bern-Klug, 2004).  Another theory related to 
assessing end-of-life matters takes into consideration differing courses of degeneration.  
The “trajectories of decline” model insinuates that those with chronic illness follow one 
of three paths: long-term decent functioning with a quick decline to death in weeks or 
months, slow decline with sudden death during an episode of exacerbation, or long-term 
diminishing function necessitating years of personal care (Batchelor, 2010).  Estimates 
propose that 20% of individuals experience the first trajectory, while 25% and 40% 
experience trajectory two and three; only about 15% of deaths appear to relate to sudden 
illness or accidents (Batchelor, 2010).  The difficulties involved in anticipating death for 
Americans requiring long-term care, along with uncertainties regarding methods of 
treatment and the tendency to ignore end-of-life matters until it is too late, creates the 
need for urgent improved attention to the process of dying. 
 
     2.2.3 Conditions of Death 
 While the majority of Americans report a preference for home death, many face 
end-of-life in less desirable surroundings.  Systematic literature reviews illustrate the 
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importance of dying at home for 59% to 81% of the general population; however, around 
half of all chronic disease-related deaths in 2001 still occurred in acute care hospitals 
(Gruneir et al., 2007).  Avoiding death in the acute care setting does not necessarily 
translate to the desired home death for the remaining half of the population, though.  The 
proportion of nursing home deaths has grown rapidly in the past 12 years, with around 
25% of Americans facing end-of-life in such institutions (Gruneir et al., 2007).  Like 
many other aspects of healthcare, disparities related to place of death are well 
documented.  For example, one U.S. study reports that only about 16% of dementia 
patients die in the acute care setting, as compared to the 50% average rate experienced by 
most chronic patients, and that, instead, 67% experience dementia-related death in 
nursing homes (Mitchell, Teno, Miller, & Mor, 2005).  In addition to disease-related 
disparities, other factors have also been linked to place of death.  Studies show that being 
White or living in less racially diverse areas predicts a home death, whereas being a 
minority predicts death in the acute care setting (Gruneir et al., 2007).  Also, higher odds 
of hospital death are cited for less educated individuals or those who have less access to 
social support (Gruneir et al., 2007). 
 Regarding preference, place of death is not the only important factor influencing 
the end-of-life experience.  Research, both domestic and abroad, demonstrates that a 
meaningful death includes important concepts such as timeliness and lack of pain, and 
that emphasizing the value of personal relationships and promoting feelings of 
connectedness remain priorities for dying patients and their families (Long, 2004).  The 
“meaningful death”, however, is only one of many definitions related to the notion of 
dying well.  Another popular framework, the “good death”, promotes physical and 
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psychological comfort, awareness, agency, and autonomy and acceptance, ending in 
peaceful closure (Watts, 2012).  Additionally, the “dignified dying” concept stresses 
psychological and spiritual care, patient autonomy and control, quality of interactions, 
and privacy boundaries during the end-of-life journey (Coenen, Doorenbos, & Wilson, 
2007).  Moreover, the “respectful death model” focuses more broadly on professional 
caregivers building personal, close relationships with patients and families to provide 
overall support during end-of-life (Wasserman, 2008).  Although many of the concepts 
fostering positive end-of-life experiences contain slight variations, overall, they generally 
define aspects that lead to the avoidance of negative or bad death situations. 
 Evidence suggests that place of death and the odds of a positive death experience 
may be strongly correlated, which, for many Americans, translates to undesirable 
circumstances.  Much of the literature regarding hospital-based deaths demonstrates 
overaggressive measures and lack of comfort care, as perceived by family members, with 
loved ones experiencing end-of-life symptoms like pain, shortness of breath, and 
dysphoria (Galanos et al., 2012).  Research supports the view that hospitals often offer 
surroundings incompatible with a good death.  For example, one study estimates that 
around 50% of hospital staff and over 70% of nurses know their dying patients for less 
than two days, and that attending physicians, nurses, and other medical staff rarely ever 
agree on proper end-of-life care protocol (Galanos et al., 2012).  Likewise, research also 
validates that end-of-life care in the nursing home is deemed less than exemplary and is 
the institution with, perhaps, the greatest room for improvement (Bern-Klug, 2009).  
Well-documented complaints portray nursing home physicians as “missing in action” and 
criticize hospice enrollment rates that occur too late, as well as the tendency for residents 
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to be transferred to hospital intensive care units as they near death (Bern-Klug, 2009). 
Accordingly, uncertainty remains regarding the ability of institutions to facilitate positive 
death experiences by providing necessary components such as education and 
explanations for family members, grief work facilitation, and advocacy of patient wishes 
(Coenen et al., 2007). 
 Considering the statistics related to disparities in place of death and the lack of 
evidence regarding the potential for a positive death experience in institutions, racial 
minorities or individuals of lower SES seem to exhibit an unfair disadvantage in terms of 
dying well.  A multitude of analyses have not only validated disparities, but at the same 
time have also exposed unsettling data.  For instance, one study illustrated that cancer-
diagnosed African Americans have increased odds for under treatment of pain, while 
another report documented the likelihood of greater wait times for pain medication 
administration for African American patients, regardless of diagnosis (Hazin & Giles, 
2011).  Analogously, an additional article declares that patients in facilities having 
primarily minority residents are three times more likely to be under medicated than those 
in institutions with residents of a majority population (Hazin & Giles, 2011).  Along with 
race and ethnicity and SES, other determinants of quality end-of-life care, like age and 
expected death, have also been explored.  A recent study looking at end-of-life care in the 
hospital setting shows that patients under 75 years of age received worse overall care than 
those 75 or older (Walling et al., 2010).   Moreover, patients whose charts indicated 
expected death three or more days before the actual occurrence experienced more 
effective pain control than those with no such documentation (Walling et al., 2010).  The 
realities of widespread disparities in end-of-life care, together with the flawed institution-
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centered death model, leave much to be desired during Americans’ final days of life.  
Although the U.S. spends almost twice as much per capita on healthcare than the 23 most 
developed nations worldwide spend on average, end-of-life medical care remains 
severely underfunded; the Economist Intelligence Unit ranks the U.S. 31 out of 40 
countries in this regard (Hoefler, 2010).  Disturbingly, according to the same report, the 
U.S. ranks 9th for overall quality of death, followed closely by Hungary and Poland 
(Hoefler, 2010).  
 
2.3 End-of-Life Care in the U.S. 
     2.3.1 Palliative Care 
 In response to the fragmented end-of-life medical care most Americans receive, 
the palliative care movement has recently gained momentum.  Keeping the focus on 
quality of life, regardless of diagnosis, palliative care is intended to provide comfort and 
support to patients and families, irrespective of whether they choose to pursue curative 
treatments (Meier, 2011).  The palliative care model may be delivered in multiple settings 
– the home, hospital, nursing home, or assisted living facility – and consists of an 
interdisciplinary team of healthcare professionals who address disease, mental health, 
family and social relationships, and spiritual needs (Meier, 2011).  Proponents advocate 
that palliative care should be practiced simultaneously with therapeutic efforts from the 
moment a life-threatening illness is diagnosed, taking the form of primary, secondary, or 
tertiary care (Meier, 2011).  At the primary level, all physicians should strive to control 
pain and symptoms; however, at the secondary level, many times the services of a 
palliative care specialist are required for more complex situations.  Additionally, 
palliative care efforts may involve research or teaching at the tertiary level (Meier, 2011).  
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Patients most often benefiting from palliative care services include those that are 
struggling with a chronic disease that will one day lead to death or the elderly suffering 
from overall debility and distress; nevertheless, few restrictions regarding patient-related 
aspects of qualification exclude anyone in need of service (Batchelor, 2010).  Conversely, 
most of the limitations affecting access to palliative care services stems from the issue of 
reimbursement on the provider side of the spectrum.  While many professionals support 
the notion of palliative care, reimbursement for certain services through Medicaid, 
Medicare, and private insurance is not always guaranteed, forcing the institution to bear 
any uncovered costs (Lubell, 2010).  Currently, providing palliative care in the hospital 
setting is the only way to ensure the most comprehensive reimbursement for healthcare 
providers’ services; still, assistance from team members like chaplains, social workers, 
and bereavement counselors is never considered billable in the palliative setting (Lubell, 
2010). 
 Due to the restrictions placed on palliative care reimbursement, most programs 
providing such services focus on the in-patient hospital environment.  Estimates suggest 
that at least 80% of hospitals with 300 or more beds offer formal palliative care programs 
(Galanos et al., 2012).  Even with availability of services in larger hospitals, one study, 
examining end-of-life care at a well-respected university medical center, highlights the 
truths associated with access to palliative care – only 7% of patients hospitalized for three 
or more days were engaged in a palliative care consultation (Walling et al., 2010).  
Similarly, in another study enrolling almost 1600 patients across 35 university hospitals, 
palliative care consults were ordered for only about 13% of patients meeting end-of-life 
criteria (O’Mahony et al., 2008).  Given the difficulties related to reimbursement outside 
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of the hospital, it is not uncommon to find poorer access to formal palliative care or end-
of-life programs in the nursing home setting.  A nationally representative study recently 
reported that out of nearly 1200 nursing homes, only about 17% of facilities even offered 
a formal palliative care program at all (Resnick et al., 2009).  Furthermore, the data 
suggests that patients have a greater chance of being offered specialty end-of-life 
programs in independent nursing homes, as well as in facilities that have fewer than 50 
beds (Resnick et al., 2009).   
 When examining evidence addressing the efficacy of palliative care treatment at 
end-of-life, it becomes apparent that few Americans receive holistic comfort care, 
regardless of their diagnosis and decisions to pursue curative or restorative measures.  
The literature presents little evidence suggesting that palliation is ineffective.  On the 
contrary, a recent systematic review looking at specialist palliative care teams and cancer 
patients found that out of eight relevant randomized controlled trials, seven merited a 
ranking of moderate to high evidence, providing significant outcome improvements for 
pain and symptom control, reduced anxiety, and reduced hospital admissions (Higginson 
& Evans, 2010).  Combined with the substantiation regarding the efficacy of palliative 
care in cancer patients, a recent study looking at differences between cancer and non-
cancer patients in palliative care programs in Germany indicates that patients with non-
cancer diagnoses benefit as much from palliation – or in some cases, even more – as their 
cancer-diagnosed counterparts (Ostgathe et al., 2011).  Compared with cancer patients, 
those with non-cancer diagnoses had significantly worse functional status, significantly 
higher needs for nurse support, and died significantly more often (Ostgathe et al., 2011).  
Furthermore, the non-cancer patients were significantly more likely to suffer from 
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dyspnea, weakness, and tiredness, as well as require more wound care and assistance with 
ADL’s (Ostgathe et al., 2011).   
 
     2.3.2 Hospice Care 
 Another option for Americans facing terminal illness, hospice care offers most of 
the same services associated with palliative care, with a more distinct focus on 
approaching end-of-life.  While palliative care provides the opportunity to continue 
restorative treatments simultaneously, hospice care is intended for those individuals who 
are estimated to have six months or less to live and wish to forego curative efforts, 
concerned mainly with comfort, dignity, and quality of life remaining (Furman, Doukas, 
& Reichel, 2010).  Like the interdisciplinary team that oversees palliative care, the 
hospice team provides much needed support including physician and nursing care, as 
well as social work, counseling, chaplain and bereavement services (Lutz, 2011).  In 
addition to care services, the hospice benefit provides palliative medications, durable 
medical equipment (e.g., wheelchairs and hospital beds), and supplies (e.g., adult diapers 
and mouth care swabs) (Lutz, 2011).  According to patient preference and level of 
required support, hospice care is generally provided at a private residence, an in-patient 
hospice unit, or in the hospital setting.  As of 2010, at the time of death, 41.1% of patients 
received hospice services at their private residence, while 18% and 7.3% received care at 
nursing homes and residential facilities, respectively (“NHPCO Facts,” 2012).  
Additionally, at the time of death, 21.9% of patients received care in hospice in-patient 
facilities, and 11.4% of care was delivered in the hospital setting (“NHPCO Facts,” 
2012).  Outside of the in-patient setting, hospice services are generally regarded as 
supplementary, since the interdisciplinary team visits the home regularly, but also 
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requires the patient have a primary caregiver.  While hospice staff are not typically able 
to provide around-the-clock or even daily care, most agencies offer on-call services, in 
case any issues arise (“NHPCO Facts,” 2012).  Similar to the evidence regarding 
effectiveness of palliative care, hospice has been shown to dramatically improve the end-
of-life experience.  For instance, families exposed to hospice describe less unmet needs, 
higher quality of death, and less anxiety regarding quality of care (Teno et al., 2011). 
 Since 1982, when Congress created a national hospice benefit, many Americans 
have qualified for services under Medicare part A (Lutz, 2011).  Upon election of the 
Medicare Hospice Benefit, patients relinquish their access to the regular Medicare 
Benefit for any care related to their terminal condition (Furman et al., 2010).  
Accordingly, the Hospice Medicare Benefit covers the cost of hospice care at 100%, but 
patients are still able to access their standard Medicare Benefit for unrelated health care 
issues (Furman et al., 2010).  For Americans not enrolled in Medicare, many state 
Medicaid programs and private insurance plans also offer hospice care benefits, varying 
in their levels of out of pocket-costs, deductibles, and covered services.  As of 2010, 
almost 84% of hospice patients were covered under Medicare, with around 5% covered 
through a Medicaid program and nearly 8% covered by managed care or private 
insurance (“NHPCO Facts,” 2012).  The remaining 3% of hospice patients served in 2010 
were covered as charity cases, through self-pay, or through other similar sources 
(“NHPCO Facts,” 2012).   
 Even though there was a network of almost 5,000 U.S. hospice agencies as of 
2008, the majority of Americans still face death without the comfort and support 
provided by a qualified hospice team (Silveira et al., 2011).  Of the approximately 2.45 
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million U.S. deaths occurring in 2010, only around 1 million involved hospice services, 
signifying that nearly 58% of Americans most likely lack appropriate pain control and 
psychosocial care during their final days (“NHPCO Facts,” 2012).  Although the total 
number of Americans seeking hospice services over the past 20 years has multiplied at 
least six times, additional progress related to end-of-life care remains necessary (Johnson, 
Kuchibhatla, Tanis, & Tulsky, 2007).   In addition to increasing the reach of hospice to 
the proportion of dying Americans who are currently lacking, more work is required to 
assure that the nearly 42% of patients using hospice services take full advantage of the 
benefits.  Though the hospice benefit provides 180 days of care and potentially more, if 
the patient continues to meet terminal qualifications, roughly 62% of hospice patients in 
2010 utilized services for less than one month (“NHPCO Facts,” 2012).  Sadly, short 
lengths of service create challenges for caregivers attempting to build trusting 
relationships with patients and families, in order to foster positive deaths and provide the 
highest level of end-of-life care. 
 Akin to the theme of disparities in service access and utilization in other areas of 
health care, the literature confirms that the likelihood of receiving hospice care is not 
uniformly distributed throughout the American population.  Research shows important 
differences regarding the probability of a hospice admission in relation to many other 
crucial factors, such as sex, for example.  Not only have previous studies cited females’ 
increased odds of hospice enrollment as compared to males, but the most recent statistics 
regarding hospice use further substantiate this inconsistency (duPreez et al., 2008).  In 
2010, the majority of all hospice patients were female, with male patients representing 
only 43.9% of the total hospice patient population (“NHPCO Facts,” 2012).  In addition 
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to sex, research highlights variances in hospice utilization by age group.  In general, older 
Americans remain more likely to engage hospice services than their younger counterparts 
(Carrion et al., 2011).  More specifically, according to 2010 data, almost 39% of all 
hospice patients were 85 years or older, while around 28% were 75-84 years, roughly 
16% were 65-74 years, and about another 16% were 35-64 years of age (“NHPCO 
Facts,” 2012).   
 Another important factor appearing to influence the odds of enrolling in hospice 
care is the nature of a patient’s diagnosis.  Upon the introduction of hospice to the U.S., 
providers were focused on serving primarily individuals living with terminal cancer; 
nevertheless, there has been a recent shift in the growing number of patients receiving 
care for non-cancer terminal diseases (Johnson et al., 2007).  In fact, as of 2010, almost 
64% of all hospice patients were diagnosed with life-limiting diseases other than cancer 
(“NHPCO Facts,” 2012).  The top four non-cancer diagnoses, by percentage of hospice 
admissions, in 2010 included heart disease (14%), debility unspecified (13%), dementia 
(13%), and lung disease (8%) (“NHPCO Facts,” 2012). Diagnoses such as stroke, end-
stage renal disease, liver disease, ALS, and HIV/AIDS comprised the remainder of non-
cancer related hospice admissions (“NHPCO Facts,” 2012).   
 Closely paralleling the probability that Americans with lower SES will face less 
positive death experiences, income, wealth, and education have all been documented as 
key hospice use indicators.  For example, a study found that each $1000 increment in 
median household income corresponded to a 3% increase in hospice services supply in 
counties across the U.S., potentially creating less access to end-of-life care for those 
individuals living in more poverty-stricken areas (Silveira et al., 2011).  Another study 
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discusses their sample’s 20% hospice utilization rate for patients with incomes 300% or 
greater than the federal poverty level, as opposed to a 14% utilization rate for those with 
incomes less than 100% of the federal poverty level (O’Mahony et al., 2008).  Also 
emphasizing the issues related to SES, access to end-of-life care, and potential hospice 
utilization, the authors of one study found that populations with a lower median 
household income or lower educational attainment were significantly more likely to be 
located more than 30 minutes from a hospice than their counterparts (Carlson, Bradley, 
Du, & Morrison, 2010).   
 Perhaps the most pronounced disparities, race and ethnicity seem to play a vital 
role in the acceptance and utilization of hospice services at the end-of-life.  As of 2010, 
estimates suggest nearly 77% of all hospice patients were White, while the remaining 
patients identified as African American (8.9%), Asian/Hawaiian/Pacific Islander (2.5%), 
American Indian/Alaskan Native (.3%), or multiracial/other (11%).  Additionally, only 
around 6% identified as Hispanic/Latino (“NHPCO Facts,” 2012).  Confirming the 
accuracy of such estimates, numerous studies report the troubling underuse of hospice 
care by racial and ethnic minorities.  In one study looking at almost 23,000 hospice 
patients in Florida, around 81% of the sample was White, while around 10% were 
African American, around 9% were Hispanic, and only about 1% were Asian/Pacific 
Islander (Carrion et al., 2011).  In another analysis, assessing hospice utilization for stoke 
victims, the authors found that African Americans were significantly less likely to use 
hospice services when compared to Whites (duPreez et al., 2008).  Furthermore, another 
investigation determined that non-Whites diagnosed with heart failure were also 
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significantly less likely to enroll in hospice, as compared to their White counterparts 
(Givens et al., 2010).   
 Despite the fact that African Americans exhibit the highest mortality rates in the 
U.S., a considerable portion of the literature focuses on their underrepresentation in 
hospice care.  Although African American patients tend to report a greater need for the 
types of services provided by hospice, research clearly indicates that they do not embrace 
end-of-life care in the same manner as Whites (Fishman et al., 2009).  While many 
factors most likely result in such an outcome, treatment preferences appear to play an 
important role in the hospice utilization gap.  Opting for more aggressive care than 
Whites, African Americans have been shown to have higher rates of artificial nutrition, 
blood transfusions, and mechanical ventilation (Connolly, Sampson, & Purandare, 2012).  
Moreover, in a study looking at cancer patients, African Americans were more likely than 
Whites to continue treatment for a smaller chance of six-month survival (Fishman et al., 
2009).  Overall, the idea of giving up curative treatment treatments to enroll in hospice 
may very well create discordance with African American beliefs (Hazin & Giles, 2011).
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Chapter III 
Methods and Procedures 
 
 
3.1 Background 
 
 The data analyzed in this study were obtained from the cross-sectional 2007 
National Home and Hospice Care Survey (NHHCS), conducted by the Centers for 
Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS).  
This nationally representative data set, collected between August 2007 and February 
2008, offers descriptive information regarding home health and hospice agencies, staff, 
services, and patients (“NHHCS - National Home and Hospice Care Survey Homepage,” 
n.d.).  As part of a continuing series of surveys, the NHHCS has been conducted at 
varying intervals since 1992.  All participating hospice agencies were certified by at least 
one of the following: Medicare, Medicaid, or the state in which patients were served.  
 
3.2 Data Collection 
 Utilizing a stratified two-stage probability sample design, the NCHS first 
systematically and randomly selected 1,545 home health and hospice agencies from a 
sample frame of over 15,000 agencies (“NHHCS - National Home and Hospice Care 
Survey Homepage,” n.d.).  Then, during interviews, staff randomly selected current home 
health patients and hospice discharges from agency census lists, with the assistance of a 
computer algorithm.  After eliminating agencies outside of the scope of the survey, 
information was collected in-person from a total of 1,036 hospice and home health 
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agencies via directors and staff – no patients or patient representatives were interviewed.  
Agency interviews, along with information collected from medical records, provided 
details for a total of 9,416 current home health patients and hospice discharges after 
eliminating those outside of the survey scope.  Of the 9,416 final patients/discharges 
surveyed, 4,733 were hospice cases.  Data available for these cases include details such 
as age, sex, race and ethnicity, diagnoses, and medications taken. 
 
3.3 Variables Selected 
 From the available data, the following sociodemographic (independent) variables 
were chosen for this analysis: sex, age at time of discharge, Hispanic/Latino ethnicity, 
race, primary source of payment for hospice care, and deceased status upon discharge.  
Regarding sex, response options were limited to male or female.  The data set treated age 
at time of discharge as a continuous variable; therefore, responses were recoded into the 
following categorical groups for the purposes of this study: 18-34, 35-64, 65-74, 75-84, 
and 85+.  The question regarding Hispanic/Latino ethnicity was answered with a simple 
yes or no response.  Regarding race, options included White, Native Hawaiian/Pacific 
Islander, African American, Asian, American Indian/Alaska Native, and other.  
Discharges could be classified as more than one race, and those with an “other” response 
were treated as missing.  Regarding source of payment, discharges were primarily 
covered by one of the following: Medicare, Medicaid, TRICARE (formally CHAMPUS), 
Department of Veterans Affairs, CHAMPVA, other government, private insurance, long-
term care insurance, self-pay (patient/family), no charge for care, payment source not 
determined, or other.  In order to make results more manageable, the variable was 
recoded into the following options: no charge/other, self-pay, private insurance, other 
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government, Medicaid, or Medicare.  For deceased status upon hospice discharge, 
responses included a simple yes or no answer.   
 In addition to selected sociodemographic variables, clinical (independent) 
variables were also analyzed in this study, including location hospice was initiated, length 
of stay in days, level of care at discharge, number of ADL’s requiring help, cognitive 
function at admission/currently, and symptoms of dyspnea, depression, or pain at last 
visit.  Categorical options for the question, “where was patient staying when (he/she) first 
began receiving hospice care?” (location hospice initiated), were: agency’s 
inpatient/residential facility, private home or apartment, residential care place, skilled 
nursing facility (nursing home), hospital, or other.  The data set treated “number of days 
patient received hospice care” (length of stay) as a continuous variable, which, for the 
purpose of this study, was recoded into five corresponding categories: 180+, 90-179, 30-
89, 8-29, and < 7.   
 Categorical possibilities regarding level of care at discharge included routine 
home care, continuous home care, general inpatient care, and respite care.  Cases 
classified as unknown, refused, or inapplicable were treated as missing.  Regarding the 
number of ADL’s requiring help, which includes assistance with bathing, dressing, 
transferring, walking, or eating, available categorical responses were zero to five.  Again, 
those cases classified as unknown, refused, or inapplicable were treated as missing.  For 
mental status (cognitive function at admission/currently), categorical responses included 
no cognitive impairment, requires occasional reminders, requires situational assistance, 
requires routine assistance, or severe cognitive impairment; unknown, refused, or 
inapplicable selections were treated as missing.  Symptoms of dyspnea, pain, and 
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depression at last visit were treated as simple categorical yes or no responses.  Cases with 
unknown, refused, or inapplicable selections were treated as missing, as well. 
 The dependent variable in this analysis – hospice diagnosis – was determined 
from the response to each discharge’s primary admission diagnosis when first beginning 
hospice service.  Potential responses included any valid International Classification of 
Diseases (ICD-9) code.  For comparison purposes, all ICD-9 diagnosis codes were 
recoded into a main categorical variable, producing two independent groups: cancer vs. 
non-cancer. 
 
3.4 Statistical Analysis 
 All statistical analysis was performed using PASW Statistics 18 (SPSS, Inc., 
2009, Chicago, IL).  In order to determine the distribution of diseases for the sample of 
discharges, ICD-9 codes were recoded into their corresponding categorical diagnosis 
groups.  Prevalence of disease was then determined by running descriptive frequencies.  
Additionally, descriptive frequencies were also run for all sociodemographic and clinical 
variables, in order to determine the prevalence of each.  Next, the two diagnosis groups 
(cancer vs. non-cancer) were compared by each sociodemographic and clinical variable 
through chi-square tests of independence, evaluating the existence of any between-group 
differences.  Differences were considered significant for p-values less than 5%.  In order 
to better describe relationships between the sociodemographic and clinical variables and 
hospice diagnosis, logistic regression was performed.  Any independent variables that 
differed significantly during chi-square testing were evaluated for association with 
hospice diagnosis through univariate logistic regression procedures.  Finally, in an 
attempt to control for potential confounders, all independent variables with significant 
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chi-square results were combined in one multivariate logistic regression model.  Overall 
relationships were determined by odds ratios, and significance was indicated by 95% 
confidence intervals.
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Chapter IV 
Results 
 
 
4.1 Distribution of Diseases 
 The 2007 NHHCS dataset contained a total of 9,416 patient cases.  Of those, 
3,905 cases met study inclusion criteria: having a hospice discharge, being a patient age 
18 or over, and detection of complete survey responses for selected variables.  In terms of 
disease prevalence (Table 1), 1,865 (47.8%) discharges entered hospice care with a 
cancer diagnosis.  The remaining 2,040 (52.2%) discharges entered with a non-cancer 
diagnosis.  The top non-cancer diagnoses were comprised of discharges exhibiting 
diseases of the circulatory system; 614 (15.7%) individuals suffered from illnesses such 
as heart disease, heart failure, or cerebrovascular disease.  The second most common non-
cancer group, “other”, included mainly those diagnosed with failure to thrive or debility 
unspecified and contained 485 (12.4%) discharges.  Respiratory system illnesses ranked 
third, as 304 (7.8%) discharges were diagnosed with diseases such as pulmonary fibrosis 
or chronic airway obstruction.  Ranking fourth, 234 (6%) discharges were diagnosed with 
nervous system disorders, including Parkinson’s disease, multiple sclerosis, and muscular 
dystrophy.  The fifth most common non-cancer diagnosis included organic psychotic 
conditions such as dementia – 206 (5.3%) discharges exhibited these types of terminal 
diseases.  Other less common non-cancer diagnoses represented were HIV/AIDS and 
diseases of the digestive, genitourinary, and musculoskeletal systems.
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4.2 Comparison of Cancer/Non-cancer Diagnoses by Sociodemographics 
 Evaluating the prevalence of selected sociodemographic variables in relation to 
hospice diagnosis (Table 2), the majority of the non-cancer group, 1,228 (60.2%) 
discharges, identified as female, while the majority of the cancer group, 959 (51.4%) 
discharges, identified as male.  Accordingly, a significant difference regarding sex 
prevailed between the two hospice diagnosis groups (X2 (1) = 53.052, p < .001).  For non-
cancer diagnoses, an age of 85 years or older was most common, with 1,011 (49.6%) 
discharges classified in the corresponding age range.  In contrast, the most common age 
for a cancer diagnosis ranged between 75 and 84 years, with this category including 605 
(32.4%) discharges.  A significant age difference between the two hospice diagnosis 
groups was discovered (X2 (4) = 612.399, p < .001).  Comparing ethnicity between the 
two hospice diagnosis groups, 52 (2.5%) non-cancer discharges and 54 (2.9%) cancer 
discharges were reported as having a Hispanic/Latino origin.  No significant difference 
between the two diagnosis groups was found in regards to ethnicity (X2 (1) = .443, p = 
.506).   
  The majority of both non-cancer and cancer hospice discharges were White, 
totaling 1,842 (90.3%) and 1,727 (92.6%), respectively.  Analysis showed a significant 
difference in White racial status between the two diagnosis groups (X2 (1) = 6.591, p = 
.010).  The second most common racial status was African American, with 154 (7.5%) 
non-cancer discharges and 108 (5.8%) cancer discharges represented.  Results exposed a 
significant difference in African American racial status between the two diagnosis 
groups, as well (X2 (1) = 4.811, p = .028).  No significant differences between diagnosis 
groups were discovered regarding Native Hawaiian/Pacific Islander, Asian, and 
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American Indian/Alaska Native racial status.  For primary source of payment, most 
utilized Medicare benefits – 1,909 (93.6%) non-cancer discharges and 1,341 (71.9%) 
cancer discharges.  However, a significant difference was noted when comparing the two 
diagnosis groups in terms of primary payment source (X2 (5) = 343.545, p < .001).  Upon 
discharge, 1,511 (74.1%) non-cancer diagnosed hospice patients and 1,641 (88%) cancer 
diagnosed hospice patients were deceased, highlighting a significant difference between 
the two groups’ prevalence of death (X2 (1) = 121.302, p < .001).   
 
4.3 Comparison of Cancer/Non-cancer Diagnoses by Clinical Characteristics 
 Upon assessment of the prevalence of selected clinical variables in relation to 
hospice diagnosis (Table 3), private residences and nursing homes were the most 
common locations hospice was initiated for both diagnosis groups.  For the non-cancer 
group, 1,058 (51.9%) discharges began hospice service at home, while 585 (28.7%) 
discharges were served in a nursing home.  In the cancer group, 1,459 (78.2%) discharges 
also received care at their home, and 179 (9.6%) discharges participated in a hospice 
program in a nursing home facility.  Overall, a statistically significant difference was 
detected in the location of hospice service initiation between the two groups (X2 (5) = 
358.319, p < .001).  Regarding length of stay, 1,015 (49.8%) non-cancer discharges and 
1,144 (61.4%) cancer discharges received 29 days or less of hospice care services.  
Correspondingly, only 376 (18.4%) non-cancer and 120 (6.4%) cancer discharges 
received hospice services for at least 180 days.  The between group differences related to 
length of stay were found to be statistically significant (X2 (4) = 171.772, p < .001).  
Examining the level of care at time of discharge, most non-cancer and cancer discharges 
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were classified as routine homecare, and the difference between both groups did not hold 
significance (X2 (3) = .704, p = .872). 
 Most discharges in both diagnosis groups required assistance with three to five 
ADL’s.  Assistance with four ADL’s was the most common response, as evidenced by 
649 (31.8%) non-cancer and 520 (27.9%) cancer discharges’ needs.  Results indicate 
significant differences between the two groups and their requirement of assistance with 
ADL’s (X2 (5) = 148.092, p < .001).  In terms of level of cognitive function at 
admission/currently, the most common response for the non-cancer diagnosed group was 
the need for routine assistance, with 626 (30.7%) discharges included.  However, the 
most common response for the cancer diagnosis group was no cognitive impairment, with 
880 (47.2%) discharges included.  Differences in cognitive function at 
admission/currently significantly differed between the two diagnosis groups (X2 (4) = 
524.468, p < .001).  Upon assessment of symptoms that were present at the most recent 
hospice visit, 872 (42.7%) non-cancer discharges experienced dyspnea, as opposed to the 
894 (47.9%) cancer discharges exhibiting the same issue.  This symptomatic difference 
between the two groups proved statistically significant (X2 (1) = 10.596, p < .001).  With 
181 (8.9%) non-cancer discharges and 138 (7.4%) cancer discharges reported as 
depressed, such between group differences remained insignificant (X2 (1) = 2.818, p = 
.093).  Finally, when addressing pain, 521 (25.5%) non-cancer discharges and 708 (38%) 
cancer discharges faced challenges.  Like dyspnea, analysis of pain presence during the 
previous hospice visit resulted in significant differences between the two diagnosis 
groups (X2 (1) = 69.721, p < .001). 
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4.4 Univariate Logistic Regression 
 Univariate logistic regression analysis revealed quite a few important predictive 
relationships between the classification of terminal hospice diagnosis (cancer vs. non-
cancer) and selected sociodemographic and clinical variables (Table 4).  Regarding the 
relationship with sex, females appeared significantly less likely to enter hospice with a 
cancer diagnosis than males (OR = 0.625; 95% CI: 0.550, 0.709).  Considering a link 
with age, hospice discharges in the 75-84 age range were significantly less likely to enter 
hospice care with a cancer diagnosis, as compared to other age groups (OR = 0.226; 95% 
CI: 0.064, 0.797).  Similarly, the 85+ age group also proved significantly less likely to 
have a cancer diagnosis at time of admission (OR = 0.072; 95% CI: 0.020, 0.256).  
Concerning an association with race, White hospice discharges were significantly more 
likely to admit with a cancer diagnosis (OR = 1.345; 95% CI: 1.072, 1.688), while 
African American’s were significantly less likely to do so (OR = 0.753; 95% CI: 0.584, 
0.971).  Examining a potential relationship with primary payment source, results 
indicated that hospice discharges with private insurance were significantly more likely to 
have a cancer diagnosis (OR = 3.246; 95% CI: 1.809, 5.824), and that those with 
Medicare were significantly less likely to enter hospice care with cancer (OR = 0.337; 
95% CI: 0.206, 0.551).  Also, discharges that were deceased were significantly more 
likely to have been diagnosed with cancer (OR = 2.565; 95% CI: 2.161, 3.044).   
 Results proved significant for three of the six categories related to place of 
hospice service initiation.  Hospice discharges beginning care in their private homes were 
more likely to have a cancer diagnosis (OR = 1.915; 95% CI: 1.400, 2.619), whereas 
those initiating care in a nursing home were less likely to have cancer (OR = 0.425; 95% 
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CI: 0.301, 0.601).  Additionally, hospice discharges beginning services in residential care 
facilities were even less likely to have a cancer diagnosis (OR = 0.313; 95% CI: 0.196, 
0.500).  Regarding length of stay, hospice discharges receiving less than 180 days of 
services were all significantly more likely to belong to the cancer diagnosis group.  
However, discharges receiving only 8-29 days of hospice care were significantly most 
likely to be admitted with cancer (OR = 4.238; 95% CI: 3.345, 5.370).  In terms of 
needing help with ADL’s, hospice discharges requiring assistance with two to five 
activities were all significantly less likely to have a cancer diagnosis documented.  
Hospice discharges that struggled with five ADL’s were least likely to be diagnosed with 
cancer (OR = 0.284; 95% CI: 0.220, 0.366).  Looking at cognitive function upon 
admission/currently, hospice discharges with any level of impairment whatsoever were 
deemed significantly less likely to belong to the cancer diagnosis group.  Particularly, 
discharges with severe cognitive impairment were the least likely to enter hospice care 
with cancer (OR = 0.095; 95% CI: 0.073, 0.124).  Lastly, significant associations were 
found in relation to both dyspnea and pain symptoms and hospice diagnosis.  Discharges 
that experienced dyspnea were more likely to have cancer (OR = 1.233; 95% CI: 1.087, 
1.399), as were those patients who faced pain (OR = 1.784; 95% CI: 1.556, 2.045).   
 
4.5 Multivariate Logistic Regression Model 
 When controlling for potential confounders in the multivariate logistic regression 
model (Table 5), many of the associations between hospice diagnosis and 
sociodemographic and clinical variables remained significant; however, noteworthy 
changes occurred.  One of the relationships no longer considered significant, females 
were found only very slightly less likely to admit to hospice with a cancer diagnosis 
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when compared to males (OR = 0.920; 95% CI: 0.787, 1.074).  Another adjustment, the 
only significant relationship between age and diagnosis was found in the 85+ group, as 
they continued to be much less likely to enter hospice care with a cancer diagnosis (OR = 
0.254; 95% CI: 0.066, 0.976).  In addition to sex, race was determined to be of no 
significant relation to hospice diagnosis for both White (OR = 1.664; 95% CI: 0.930, 
2.975) and African American discharges (OR = 1.273; 95% CI: 0.667, 2.430).  Regarding 
primary source of payment, multivariate regression indicated that the only significant 
association with hospice diagnosis remained private insurance, which led to a greater 
likelihood of having cancer (OR = 2.458; 95% CI: 1.268, 4.765).  While still proving 
significantly related to the chance of a cancer diagnosis, the odds ratio for being deceased 
upon hospice discharge increased slightly (OR = 3.041; 95% CI: 2.440, 3.790).   
 The only significant association between hospice diagnosis group and location of 
hospice initiation was found for those discharges located at a private residence.  
Beginning hospice service in one’s own home predicted a much greater chance of cancer 
diagnosis (OR = 1.806; 95% CI: 1.243, 2.625).  Like the results from univariate analysis, 
all lengths of stay shorter than 180 days were significantly associated with increased 
chances for a cancer diagnosis.  Moreover, a length of stay ranging from 8-29 days 
carried the highest odds of being linked to a cancer diagnosis (OR = 3.043; 95% CI: 
2.296, 4.033).  Also similar to univariate results, the relationship between the number of 
ADL’s requiring help and type of cancer diagnosis continued to exist.  Hospice 
discharges requiring assistance with two to five ADL’s were found significantly less 
likely to admit with a cancer diagnosis when compared to individuals who needed help 
with zero to one activity.  Specifically, those discharges relying on assistance with three 
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ADL’s were least likely to be classified with a cancer hospice diagnosis (OR = 0.471; 
95% CI: 0.339, 0.655).  Additionally, the association in regards to level of cognitive 
function at admission/currently and hospice diagnosis continued to show significance.  
All levels of cognitive function involving any impairment, even if only slight, predicted 
less chance for a cancer diagnosis, with severe cognitive impairment being the least likely 
(OR = 0.148; 95% CI: 0.108, 0.201).  Finally, while pain symptoms still proved 
significantly related to hospice diagnosis, predicting an increased chance that a discharge 
admitted for cancer (OR = 1.583; 95% CI: 1.338, 1.872), the association between 
diagnosis and dyspnea lost significance (OR = 0.855; 95% CI: 0.731, 1.002).
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Chapter V 
Discussion and Conclusion 
 
 
 This study explores potential disparities related to the use of hospice care, as 
observed between individuals who presented with terminal cancer diagnoses versus those 
who presented with other non-cancer terminal diseases.  Of particular interest were 
details regarding main differences between the two hospice diagnosis groups and the 
degree to which hospice patient characteristics are related.  After controlling for both 
sociodemographic and clinical variables in a multivariate logistic regression model, 
results confirmed significant relationships between a cancer vs. non-cancer hospice 
diagnosis classification and multiple patient characteristics, largely those of clinical 
nature.  However, important differences concerning sociodemographics also emerged.   
 Descriptive analysis showed that the majority of hospice discharges involved in 
this study were seeking comfort care for a non-cancer related disease.  The most common 
non-cancer diagnoses consisted of conditions such as heart disease, cerebrovascular 
disease, failure to thrive, debility unspecified, and pulmonary disease.  While results do 
parallel other data suggesting a non-cancer majority, findings from this study regarding 
estimated proportions of cancer vs. non-cancer diagnoses differ slightly.  Another U.S. 
study, looking at racial differences and non-cancer hospice diagnoses, found that only 
around 40% of their sample presented with cancer, in comparison to the nearly 48% in 
this study (Johnson et al., 2007).  Although not entirely nationally representative, their 
sample did include patients from eight states in differing geographic locations.
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Accordingly, it is more likely that their observation of less cancer patients relates to a 
larger sample size, including approximately 162,000 more cases than this study.  In terms 
of distribution of non-cancer terminal disease, results from this study generally agree 
with the National Hospice and Palliative Care Organization’s most recent findings from 
2010 data (“NHPCO Facts,” 2012). 
 Descriptive analysis also revealed that over 90% of all hospice discharges 
included in this study identified as White, racially.  In comparison, only about 7% of total 
discharges identified as African American.  The remaining minority identified racially as 
American Indian or Alaska Native (~1%), Asian (~1%), or Native Hawaiian or Pacific 
Islander (.2%).  In terms of ethnicity, only about 3% of discharges were considered to be 
of Hispanic or Latino origin.  While certainly concerning, the racial divide found in this 
study is not a new concept.  In a study conducted in Florida around the same time, 
authors reported their sample to be primarily represented by White patients (~81%), 
while African Americans accounted for almost 10%, Asian Americans or Pacific 
Islanders accounted for .5%, and around 9% were of Hispanic ethnicity (Carrion et al., 
2011).  It is quite possible that the minimal differences in terms of racial composition 
between the two studies may be attributed to their less-generalizable sample, gathered 
from only one agency in central Florida.  While differences in comfort care utilization 
likely stem from multiple causes, research has shown that some races, particularly 
African Americans, often have misconceptions about hospice services or lack awareness 
of such care altogether (Enguidanos, Kogan, Lorenz, & Taylor, 2011).  Also related to 
race, culture and spirituality/religion have been found to shape end-of-life decisions, 
remarkably those addressing treatment options (Bosma, Apland, & Kazanjian, 2010).   
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 The comparison of cancer to non-cancer hospice discharges in this study revealed 
significant sociodemographic and clinical differences between the two diagnosis groups, 
potentially pointing to important hospice utilization disparities.  Thus, each significant 
between-group difference was further examined in an attempt to more concretely 
describe relationships between variables.  Addressing sex, women comprised the majority 
of non-cancer diagnoses and males dominated the cancer group, as comparably noted in 
other palliative care research (Ostgathe et al., 2011).  It is possible that observed sex 
differences in hospice utilization might stem from inherent biological processes affecting 
disease epidemiology – those that also play a role in the average life expectancy gap 
between American males and females.  Interestingly, although unadjusted odds of a 
cancer diagnosis were significantly lower for females during regression analysis, final 
adjusted odds resulted in no significant relationship between sex and hospice diagnosis.   
 Though all racial minorities utilized hospice much less than Whites, there were no 
significant racial differences found between non-cancer and cancer diagnoses for 
American Indians/Alaska Natives, Asians, or Native Hawaiians/Pacific Islanders.  
Nevertheless, African Americans admitted significantly more for non-cancer diagnoses, 
while Whites were significantly more often diagnosed with cancer.  Since hospice 
services generally require patients to forego curative efforts for comfort care, this 
observation is logical, as research has shown African Americans many times elect more 
aggressive measures than Whites, expressly when continuing cancer treatments (Fishman 
et al., 2009).  Much like the analysis of sex, unadjusted odds of a cancer diagnosis were 
significantly higher for Whites and lower for African Americans, but no significant 
relationship resulted when examining adjusted odds in regards to race and diagnosis.  It is 
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important to note, however, that the 95% confidence intervals were very close to 
significance for both sex and White race variables.  The listwise method utilized in 
cleaning data for this study could be one potential explanation for the barely insignificant 
adjusted results, depending on whether a disproportionate number of African American 
cases were missing data and excluded from analysis. 
 Examining differences in age, the non-cancer group was mostly comprised of 
discharges 75 years and older.  On the other hand, the majority of cancer diagnoses 
occurred in discharges ages 35-84.  Similarly, one study reported a majority of non-
cancer patients over the age of 65 and majority of cancer patients age 65 or under, which 
suggests that cancer may more often affect those in adulthood or middle age than those 
considered old (Johnson et al., 2007).  In this study, regression analysis produced 
adjusted odds indicating that discharges 85 and older are significantly less likely to enroll 
with a cancer hospice diagnosis.  The Johnson study found the same significant 
relationship for age; however, it applied to hospice patients 65 and older.  The conflicting 
age results may be related to the number of categories included in each analysis – this 
study contained five age categories, while theirs only utilized two. 
 In terms of medical coverage, the results of this study agree with previous 
research.  Even though the majority of all discharges used Medicare as a primary 
payment source, private insurance or Medicaid covered those with cancer diagnoses more 
often than their non-cancer counterparts.  Such a finding may be substantiated by the fact 
that nearly 30% of all cancer discharges were between the ages of 18 and 64, creating 
increased likelihood for Medicare ineligibility.  Ultimately, adjusted odds signify that 
private insurance increases the chances of admitting with cancer, which has also been 
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shown in other studies looking at health maintenance organizations and hospice 
diagnoses (Johnson et al., 2007).   
 Regarding status upon hospice discharge, fewer non-cancer diagnosed individuals 
were deceased when compared to those with cancer.  Additionally, adjusted odds 
validated the relationship between discharge status and diagnosis, showing that cancer 
diagnoses are significantly more likely to be deceased at the end of their hospice stay.  
Compared with other research, this finding certainly makes sense.  Estimates exist 
claiming that live discharges occur anywhere from 6-15% of the time, due to improved or 
stabilized conditions or the decision to pursue more aggressive treatment.  Furthermore, 
studies show that live discharge status and a non-cancer diagnosis are related (Enck, 
2011). 
 While more cancer than non-cancer discharges began hospice services at their 
private homes, the opposite was observed with regards to beginning services at 
residential care facilities and nursing homes.  Accordingly, multivariate regression 
specified a significant relationship between location of hospice initiation and diagnosis, 
providing that discharges beginning hospice at home were more likely to have cancer.  
Such a finding seems appropriate, due to the fact that facilities offer additional services 
unavailable in the home, and research has shown that non-cancer hospice patients exhibit 
poorer functional status and higher needs for nursing support (Ostgathe et al., 2011).  
Moreover, results from this study also support a functionality difference – more cancer 
discharges required assistance with zero to one ADL’s and had little to no cognitive 
impairment, whereas more non-cancer discharges needed help with three to five ADL’s 
and displayed significantly less cognitive function.  Along the same lines, adjusted odds 
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showed that needing assistance with more than one ADL, as well as exhibiting cognitive 
impairment at any level, led to decreased chances of a cancer diagnosis. 
 In addition to the majority of all discharges receiving hospice services for less 
than three months, this study provided that those with non-cancer diagnoses more often 
had greater length of stays, while those with cancer diagnoses were more often enrolled 
for eight days to three months.  Not only has evidence validated that most hospice 
referrals occur too late in the dying process, but studies also show that the problem is 
further compounded by the physician reimbursement incentives related to continuing 
curative treatments, as often seen with cancer patients (Hoefler, 2010).  In this study, 
multivariate regression results indicated a significantly greater chance of a cancer 
diagnosis for any length of stay less than 180 days; however, a length of stay of 29 days 
or less held the highest predictive value.   
 Finally, assessing differences in symptoms between the two diagnosis groups, 
pain and dyspnea were indicated more often for cancer patients, but no significant 
difference existed for depression.  Although another study comparing cancer and non-
cancer patients reported no significant difference in pain and a significantly greater 
amount of non-cancer patients suffering from dyspnea, conflicting results may be 
attributed to potential variance of specific cancer diagnoses included in each sample, as 
some malignancies have the ability to cause more pain and symptoms than others (Given, 
Given, Azzouz, Kozachik, & Stommel, 2001).  In this sample, final adjusted odds 
indicated that discharges with pain symptoms were significantly more likely to admit 
with a cancer diagnosis.  While regression revealed a non-significant relationship 
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between hospice diagnosis and dyspnea symptoms, 95% confidence intervals came very 
close to demonstrating a significantly protective association with cancer diagnosis.   
 When comparing this study to others that also focus on disparities and hospice 
utilization, important strengths are evident.  First, this analysis includes nationally 
representative data, as provided by the CDC, National Center for Health Statistics.  The 
agencies surveyed were chosen systematically and randomly, with probability 
proportional to size, from a sample frame of over 15,000 agencies across the U.S. 
(“NHHCS - National Home and Hospice Care Survey,” n.d.).  Although it is important to 
take caution when referring to the results as generalizable, this study likely represents the 
U.S. population to a greater degree than other studies in the literature utilizing data from 
one specific hospice agency with multiple locations or vice-versa.  Another strength lies 
in the data and methods allowing for the control of confounders.  Because of a multitude 
of available variables in the data set, it was possible to analyze independent variables’ 
relationships to the dependent variable in light of several sociodemographic and clinical 
characteristics. 
 While strong in some aspects, this study certainly poses its own limitations.  
Perhaps most importantly, the analysis was based on cross-sectional survey data, making 
it impossible to evaluate true “causality”.  Since such data is gathered at only one point in 
time, prevalence odds ratios only provide potential evidence of relationships or 
associations between variables.  Another limitation of this study relates to the use of the 
listwise deletion method.  Of the original 4,733 hospice cases included in the data set, 
only 3,905 were used during final analysis, due to the fact that data was missing for key 
variables.  Although still a large sample size, the reduction in cases may have affected the 
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significance of results through changes in statistical power.  Other limitations involve the 
inability to control for religion/spirituality and SES (income and education), both of 
which have been shown to play a role in hospice utilization.  Primary payer source was 
used as proxy variable for income, as health care coverage has been directly linked with 
poverty status; however, the substitution is far from a perfect choice (Collins, Robertson, 
Garber, & Doty, 2012).  Finally, although research has pinpointed links between 
characteristics (e.g., size and location) of the agency providing care and hospice use and 
diagnosis, controls for agency differences were not included in this analysis (Johnson et 
al., 2007).  Further research is needed to more comprehensively build a multivariate 
regression model that better predicts patient characteristics’ relationships with diagnosis. 
 Overall, this study highlights important implications related to continuing 
“business as usual” in the end-of-life health care field.  Not only do results further 
confirm statistics exposing the alarmingly low utilization of hospice services in general, 
but they also validate diagnosis-specific differences in use and required care, seemingly 
driven by both individual and population-based characteristics.  In order to increase 
utilization and access rates and eliminate current disparities, patients presenting with 
certain terminal diseases may require greater provider flexibility in terms of hospice 
eligibility requirements and services offered.  Consequently, in addition to health 
education promoting general awareness of hospice benefits, it is necessary to consider 
addressing end-of-life care systematic and policy standards that may be strengthening 
hospice use disparities, such as those emphasized in this analysis.   
 Some critics suggest moving from a prognosis-based eligibility system to one that 
is needs based, for example, which may increase length of stay and allow for more 
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comprehensive care for those that are not 100% ready to give up hope for their curative 
treatment (Carlson, Morrison, & Bradley, 2008).  Another suggestion that may impact a 
reduction in hospice use disparities requires changes on the educational side of the U.S. 
health care system.  Research shows that although most medical and nursing schools 
offer some training on end-of-life matters, the average student spends less than 15 hours 
focused on the topic, and that only one-tenth of programs offer a complete palliative care 
course.  Furthermore, only about half of students spend time with a hospice patient 
(Dickinson, 2007).  Reconsidering medical education requirements may be an effective 
way to encourage physician comfort concerning the topic of death, thereby potentially 
increasing the likelihood that hospice services are addressed more frequently with 
patients.  While many possible reform options exist, each ignites its own, fueled debate 
and requires additional research to determine feasibility from both cost and logistical 
viewpoints. 
 In conclusion, this study revealed several important disparities related to the use 
of hospice between cancer and non-cancer discharges.  As determined through 
multivariate logistic regression, the following factors were found significantly associated 
with primary hospice diagnosis: age of 85+ at discharge, private insurance as a primary 
payment source, deceased status upon discharge, hospice initiation at primary residence, 
length of stay less than 180 days, requiring assistance with two to five ADL’s, level of 
cognitive function, and presence of pain.  Although not shown to be associated with 
primary diagnosis in light of the final results, sex and White racial status came extremely 
close to reaching significance.  While additional research is required to more 
meticulously describe relationships shaping cancer vs. non-cancer hospice disparities, the 
46 
	  
differences that emerged from this study offer further insight to aid in the fight against 
end-of-life care inequalities in the U.S.   
 
	  47 
References 
 
 
Ailshire, J. A., Beltrán-Sánchez, H., & Crimmins, E. M. (2011). Social characteristics 
and health status of exceptionally long-lived Americans in the Health and 
Retirement Study. Journal of the American Geriatrics Society, 59(12), 2241–
2248. doi:10.1111/j.1532-5415.2011.03723.x 	  
Baernholdt, M., Hinton, I., Yan, G., Rose, K., & Mattos, M. (2012). Factors associated 
with quality of life in older adults in the United States. Quality of Life Research: 
An International Journal of Quality of Life Aspects of Treatment, Care And 
Rehabilitation, 21(3), 527–534. 	  
Batchelor, N. H. (2010). Palliative or hospice care? Understanding the similarities and 
differences. Rehabilitation Nursing: The Official Journal of the Association of 
Rehabilitation Nurses, 35(2), 60–64. 	  
Berlau, D. J., Corrada, M. M., & Kawas, C. (2009). The prevalence of disability in the 
oldest-old is high and continues to increase with age: findings from The 90+ 
Study. International Journal of Geriatric Psychiatry, 24(11), 1217–1225. 
doi:10.1002/gps.2248 	  
Bern-Klug, M. (2004). The ambiguous dying syndrome. Health & Social Work, 29(1), 
55–65. 	  
Bern-Klug, M. (2009). A framework for categorizing social interactions related to end-of-
life care in nursing homes. The Gerontologist, 49(4), 495–507. 
doi:10.1093/geront/gnp098  	  
Bosma, H., Apland, L., & Kazanjian, A. (2010). Cultural conceptualizations of hospice 
palliative care: more similarities than differences. Palliative Medicine, 24(5), 
510–522. doi:10.1177/0269216309351380 	  
Carlson, M. D. A., Bradley, E. H., Du, Q., & Morrison, R. S. (2010). Geographic access 
to hospice in the United States. Journal of Palliative Medicine, 13(11), 1331–
1338. doi:10.1089/jpm.2010.0209 	  
Carlson, M. D. A., Morrison, R. S., & Bradley, E. H. (2008). Improving access to hospice 
care: informing the debate. Journal of Palliative Medicine, 11(3), 438–443. 
doi:10.1089/jpm.2007.0152 
48 
	  
Carrion, I. V., Park, N. S., & Lee, B. S. (2011). Hospice use among African Americans, 
Asians, Hispanics, and Whites: implications for practice. The American Journal 
of Hospice & Palliative Care. doi:10.1177/1049909111410559 	  
Cherlin, A. (2010). Demographic trends in the United States: a review of research in the 
2000s. Journal of Marriage and the Family, 72(3), 403–419. doi:10.1111/j.1741-
3737.2010.00710.x 	  
Coenen, A., Doorenbos, A. Z., & Wilson, S. A. (2007). Nursing interventions to promote 
dignified dying in four countries. Oncology Nursing Forum, 34(6), 1151–1156. 
doi:10.1188/07.ONF.1151-1156 	  
Cohen, L. L. (2008). Racial/ethnic disparities in hospice care: a systematic review. 
Journal of Palliative Medicine, 11(5), 763–768. doi:10.1089/jpm.2007.0216 
 
Collins, S. R., Robertson, R., Garber, T., & Doty, M. M. (2012). Tracking trends in 
health system performance: the income divide in health care: how the Affordable 
Care Act will help restore fairness to the U.S. health system. Issue Brief 
(Commonwealth Fund), 3, 1–24. 	  
Connolly, A., Sampson, E. L., & Purandare, N. (2012). End-of-life care for people with 
dementia from ethnic minority groups: a systematic review. Journal of the 
American Geriatrics Society, 60(2), 351–360. doi:10.1111/j.1532-
5415.2011.03754.x 	  
Dickinson, G. E. (2007). End-of-life and palliative care issues in medical and nursing 
schools in the United States. Death Studies, 31(8), 713–726. 
doi:10.1080/07481180701490602 	  
duPreez, A. E., Smith, M. A., Liou, J.-I., Frytak, J. R., Finch, M. D., Cleary, J. F., & 
Kind, A. J. H. (2008). Predictors of hospice utilization among acute stroke 
patients who died within thirty days. Journal of Palliative Medicine, 11(9), 1249–
1257. doi:10.1089/jpm.2008.0124 	  
Enck, R. E. (2011). Discharge from hospice: dead or alive? The American Journal of 
Hospice & Palliative Care, 28(1), 5–6. 	  
Enguidanos, S., Kogan, A. C., Lorenz, K., & Taylor, G. (2011). Use of role model stories 
to overcome barriers to hospice among African Americans. Journal of Palliative 
Medicine, 14(2), 161–168. doi:10.1089/jpm.2010.0380 
 
Fishman, J., O’Dwyer, P., Lu, H. L., Henderson, H., Asch, D. A., & Casarett, D. J. 
(2009). Race, treatment preferences, and hospice enrollment: eligibility criteria 
may exclude patients with the greatest needs for care. Cancer, 115(3), 689–697. 
doi:10.1002/cncr.24046 
49 
	  
Furman, C. D., Doukas, D. J., & Reichel, W. (2010). Unlocking the closed door: 
arguments for open access hospice. The American Journal of Hospice & 
Palliative Care, 27(1), 86–90. doi:10.1177/1049909109338388 	  
Galanos, A. N., Morris, D. A., Pieper, C. F., Poppe-Ries, A. M., & Steinhauser, K. E. 
(2012). End-of-life care at an academic medical center: are attending physicians, 
house staff, nurses, and bereaved family members equally satisfied? Implications 
for palliative care. The American Journal of Hospice & Palliative Care, 29(1), 
47–52. doi:10.1177/1049909111407176 	  
Given, C. W., Given, B., Azzouz, F., Kozachik, S., & Stommel, M. (2001). Predictors of 
pain and fatigue in the year following diagnosis among elderly cancer patients. 
Journal of Pain and Symptom Management, 21(6), 456–466. doi:10.1016/S0885-
3924(01)00284-6 	  
Givens, J. L., Tjia, J., Zhou, C., Emanuel, E., & Ash, A. S. (2010). Racial and ethnic 
differences in hospice use among patients with heart failure. Archives of Internal 
Medicine, 170(5), 427–432. doi:10.1001/archinternmed.2009.547 	  
Gruneir, A., Mor, V., Weitzen, S., Truchil, R., Teno, J., & Roy, J. (2007). Where people 
die: a multilevel approach to understanding influences on site of death in 
America. Medical Care Research and Review: MCRR, 64(4), 351–378. 
doi:10.1177/1077558707301810 	  
Hank, K. (2011). How “successful” do older Europeans age? Findings from SHARE. The 
Journals of Gerontology: Series B: Psychological Sciences and Social Sciences, 
66B(2), 230–236. doi:10.1093/geronb/gbq089 	  
Hazin, R., & Giles, C. A. (2011). Is there a color line in death? An examination of end-
of-life care in the African American community. Journal of the National Medical 
Association, 103(7), 609–613. 	  
Higginson, I. J., & Evans, C. J. (2010). What is the evidence that palliative care teams 
improve outcomes for cancer patients and their families? Cancer Journal 
(Sudbury, Mass.), 16(5), 423–435. doi:10.1097/PPO.0b013e3181f684e5 	  
Hoefler, J. M. (2010). United States lags on palliative care at the end of life. Journal of 
Pain and Symptom Management, 40(6), e1–3. 
doi:10.1016/j.jpainsymman.2010.08.007 	  
Huguet, N., Kaplan, M. S., & Feeny, D. (2008). Socioeconomic status and health-related 
quality of life among elderly people: results from the Joint Canada/United States 
Survey of Health. Social Science & Medicine (1982), 66(4), 803–810. 
doi:10.1016/j.socscimed.2007.11.011 	  
50 
	  
Jemal, A., Thun, M. J., Ward, E. E., Henley, S. J., Cokkinides, V. E., & Murray, T. E. 
(2008). Mortality from leading causes by education and race in the United States, 
2001. American Journal of Preventive Medicine, 34(1), 1–8. 
doi:10.1016/j.amepre.2007.09.017 	  
Jemal, A., Ward, E., Hao, Y., & Thun, M. (2005). Trends in the leading causes of death 
in the United States, 1970-2002. JAMA: The Journal of the American Medical 
Association, 294(10), 1255–1259. doi:10.1001/jama.294.10.1255 	  
Johnson, K. S., Kuchibhatla, M., Tanis, D., & Tulsky, J. A. (2007). Racial differences in 
the growth of noncancer diagnoses among hospice enrollees. Journal of Pain and 
Symptom Management, 34(3), 286–293. doi:10.1016/j.jpainsymman.2006.11.010 	  
Lehning, A. J., & Austin, M. J. (2010). Long-term care in the United States: policy 
themes and promising practices. Journal of Gerontological Social Work, 53(1), 
43–63. doi:10.1080/01634370903361979 	  
Long, S. O. (2004). Cultural scripts for a good death in Japan and the United States: 
similarities and differences. Social Science & Medicine (1982), 58(5), 913–928. 	  
Lubell, J. (2010). Easing their pain. Palliative care grows despite reimbursement issues. 
Modern Healthcare, 40(22), 30, 32–33. 	  
Lutz, S. (2011). The history of hospice and palliative care. Current Problems in Cancer, 
35(6), 304–309. doi:10.1016/j.currproblcancer.2011.10.004 	  
McLaughlin, S. J., Connell, C. M., Heeringa, S. G., Li, L. W., & Roberts, J. S. (2010). 
Successful aging in the United States: prevalence estimates from a national 
sample of older adults. The Journals of Gerontology. Series B, Psychological 
Sciences and Social Sciences, 65B(2), 216–226. doi:10.1093/geronb/gbp101 	  
Meier, D. E. (2011). Increased access to palliative care and hospice services: 
opportunities to improve value in health care. The Milbank Quarterly, 89(3), 343–
380. doi:10.1111/j.1468-0009.2011.00632.x 	  
Mitchell, S. L., Teno, J. M., Miller, S. C., & Mor, V. (2005). A national study of the 
location of death for older persons with dementia. Journal of the American 
Geriatrics Society, 53(2), 299–305. doi:10.1111/j.1532-5415.2005.53118.x 	  
Mokdad, A. H., Marks, J. S., Stroup, D. F., & Gerberding, J. L. (2004). Actual causes of 
death in the United States, 2000. JAMA: The Journal of the American Medical 
Association, 291(10), 1238–1245. doi:10.1001/jama.291.10.1238 	  
NHHCS - National Home and Hospice Care Survey. (n.d.). Retrieved July 11, 2012, from 
http://www.cdc.gov/nchs/nhhcs.htm 
51 
	  
NHPCO Facts and Figures: Hospice Care in America. (2012, January). Alexandria, VA: 
National Hospice and Palliative Care Organization. 	  
O’Mahony, S., McHenry, J., Snow, D., Cassin, C., Schumacher, D., & Selwyn, P. A. 
(2008). A review of barriers to utilization of the Medicare Hospice Benefits in 
urban populations and strategies for enhanced access. Journal of Urban Health: 
Bulletin of the New York Academy of Medicine, 85(2), 281–290. 
doi:10.1007/s11524-008-9258-y 	  
Olshansky, S. J., Goldman, D. P., Zheng, Y., & Rowe, J. W. (2009). Aging in America in 
the twenty-first century: demographic forecasts from the MacArthur Foundation 
Research Network on an Aging Society. The Milbank Quarterly, 87(4), 842–862. 
doi:10.1111/j.1468-0009.2009.00581.x 	  
Ostgathe, C., Alt-Epping, B., Golla, H., Gaertner, J., Lindena, G., Radbruch, L., & Voltz, 
R. (2011). Non-cancer patients in specialized palliative care in Germany: what are 
the problems? Palliative Medicine, 25(2), 148–152. 
doi:10.1177/0269216310385370 	  
Preamble to the Constitution of the World Health Organization as adopted by the 
International Health Conference. (1946, July 19). Retrieved from 
http://www.who.int/suggestions/faq/en/index.html 	  
Resnick, H. E., Foster, G. L., & Hickman, S. E. (2009). Nursing home participation in 
end-of-life programs: United States, 2004. The American Journal of Hospice & 
Palliative Care, 26(5), 354–360. doi:10.1177/1049909109333933 	  
Schoeni, R. F., & Ofstedal, M. B. (2010). Key themes in research on the demography of 
aging. Demography, 47 Suppl, S5–15. 	  
Silveira, M. J., Connor, S. R., Goold, S. D., McMahon, L. F., & Feudtner, C. (2011). 
Community supply of hospice: does wealth play a role? Journal of Pain and 
Symptom Management, 42(1), 76–82. doi:10.1016/j.jpainsymman.2010.09.016 	  
Sloan, F. A., Ayyagari, P., Salm, M., & Grossman, D. (2010). The longevity gap between 
Black and White men in the United States at the beginning and end of the 20th 
century. American Journal of Public Health, 100(2), 357–363. 
doi:10.2105/AJPH.2008.158188 	  
Teno, J. M., Gozalo, P. L., Lee, I. C., Kuo, S., Spence, C., Connor, S. R., & Casarett, D. 
J. (2011). Does hospice improve quality of care for persons dying from dementia? 
Journal of the American Geriatrics Society, 59(8), 1531–1536. 
doi:10.1111/j.1532-5415.2011.03505.x 	  
 
52 
	  
Trask, B. S., Hepp, B. W., Settles, B., & Shabo, L. (2009). Culturally diverse elders and 
their families: examining the need for culturally competent services. Journal of 
Comparative Family Studies, Aging: families and households in global 
perspective, 40(2), 293–303. 
 
Walling, A. M., Asch, S. M., Lorenz, K. A., Roth, C. P., Barry, T., Kahn, K. L., & 
Wenger, N. S. (2010). The quality of care provided to hospitalized patients at the 
end of life. Archives of Internal Medicine, 170(12), 1057–1063. 
doi:10.1001/archinternmed.2010.175 	  
Wasserman, L. S. (2008). Respectful death: a model for end-of-life care. Clinical Journal 
of Oncology Nursing, 12(4), 621–626. doi:10.1188/08.CJON.621-626 	  
Watts, T. (2012). End-of-life care pathways as tools to promote and support a good death: 
a critical commentary. European Journal of Cancer Care, 21(1), 20–30. 
doi:10.1111/j.1365-2354.2011.01301.x 	  
Weaver, R. R., & Rivello, R. (2006). The distribution of mortality in the United States: 
the effects of income (inequality), social capital, and race. Omega, 54(1), 19–39. 
 
	  53 
Appendix 
Statistical Summary Tables 
 
 
 
Table 1.  Distribution of Terminal Diseases, n = 3905 
!
!
Terminal Disease    n       % 
   
HIV/AIDS 7 .2 
Organic Psychotic Conditions 
     (including Dementia) 
206 5.3 
Nervous System 
     (including Parkinson’s, Multiple Sclerosis, 
     Muscular Dystrophy) 
234 6.0 
Circulatory System 
     (including Ischemic Heart Disease,  
     Heart Failure, Cerebrovascular Disease) 
614 15.7 
Respiratory System 
     (including Pulmonary Fibrosis, Chronic Airway              
     Obstruction) 
304 7.8 
Digestive System 
     (including Chronic liver disease, Cirrhosis)      
72      1.8 
Genitourinary System 
     (including Renal Failure, Chronic Kidney Disease) 
112     2.9 
Musculoskeletal System/Connective Tissue 
     (including Systemic Sclerosis, Bone Infections)  
6 .2 
Other 
     (including Failure to Thrive, Debility Unspecified) 
485 12.4 
 
Total Non-Cancer 
 
Cancer 
 
2040 
 
1865 
 
52.2 
 
47.8 
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Table 2.  Comparison of Sociodemographic Variables Between Discharges with Cancer vs. Non-
cancer Hospice Diagnoses 
Variable Non-Cancer 
(n = 2040) 
Cancer 
(n = 1865) 
Difference 
p 
    
Sex 
     Male 
     Female 
 
812 (39.8%) 
1228 (60.2%) 
 
959 (51.4%) 
906 (48.6%) 
< .001 
 
 
Age 
     18-34 
     35-64 
     65-74 
     75-84 
     85+ 
 
3 (.1%) 
143 (7%) 
265 (13%) 
618 (30.3%) 
1011 (49.6%) 
 
13 (.7%) 
530 (28.4%) 
400 (21.4%) 
605 (32.4%) 
317 (17%) 
< .001 
 
 
 
 
 
Hispanic/Latino 
Race 
     White 
     Native Hawaiian/Pacific Islander 
     African American 
     Asian 
     American Indian/Alaska Native 
52 (2.5%) 
 
1842 (90.3%) 
6 (.3%) 
154 (7.5%) 
18 (.9%) 
20 (1%) 
54 (2.9%) 
 
1727 (92.6%) 
2 (.1%) 
108 (5.8%) 
14 (.8%) 
13 (.7%) 
.506 
 
.010 
.293 
.028 
.648 
.334 
 Primary Payment Source 
     No Charge/Other 
     Self-pay 
     Private Insurance 
     Other Government 
     Medicaid 
     Medicare 
Deceased 
 
24 (1.2%) 
9 (.4%) 
42 (2.1%) 
13 (.6%) 
43 (2.1%) 
1909 (93.6%) 
1511 (74.1%) 
 
50 (2.7%) 
22 (1.2%) 
284 (15.2%) 
54 (2.9%) 
114 (6.1%) 
1341 (71.9%) 
1641 (88%) 
< .001 
 
 
 
 
 
 
< .001 
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Table 3.  Comparison of Clinical Variables Between Discharges with Cancer vs. Non-cancer 
Hospice Diagnoses 
Variable Non-Cancer 
(n = 2040) 
Cancer 
(n = 1865) 
Difference 
p 
    
Location Hospice Initiated 
     Agency Inpatient/Residential Facility 
     Private Residence 
     Residential Care Facility 
     Nursing Home 
     Hospital 
     Other 
Length of Stay in Days 
     180+ 
     90-179 
     30-89 
     8-29 
     < 7 
Level of Care at Discharge 
     Routine Homecare 
     Continuous Homecare 
 
100 (4.9%) 
1058 (51.9%) 
164 (8%) 
585 (28.7%) 
120 (5.9%) 
13 (.6%) 
 
376 (18.4%) 
235 (11.5%) 
414 (20.3%) 
485 (23.8%) 
530 (26%) 
 
1668 (81.8%) 
87 (4.3) 
 
72 (3.9%) 
1459 (78.2%) 
37 (2%) 
179 (9.6%) 
105 (5.6%) 
13 (.7%) 
 
120 (6.4%) 
151 (8.1%) 
450 (24.1%) 
656 (35.2%) 
488 (26.2%) 
 
1508 (80.9%) 
82 (4.4%) 
< .001 
 
 
 
 
 
 
< .001 
 
 
 
 
 
.872 
 
 
     GIP  265 (13%) 258 (13.8%)  
     Respite 
Number of ADL’s Requiring Help 
     0 
     1 
     2 
     3 
     4 
     5 
Cognitive Function at Admission 
     No Cognitive Impairment 
     Requires Occasional Reminders 
     Requires Situational Assistance 
     Requires Routine Assistance  
20 (1%) 
 
109 (5.3%) 
57 (2.8%) 
198 (9.7%) 
451 (22.1%) 
649 (31.8%) 
576 (28.2%) 
 
410 (20.1%) 
265 (13%) 
342 (16.8%) 
626 (30.7%) 
17 (.9%) 
 
277 (14.9%) 
127 (6.8%) 
184 (9.9%) 
342 (18.3%) 
520 (27.9%) 
415 (22.3%) 
 
880 (47.2%) 
331 (17.7%) 
303 (16.2%) 
270 (14.5%) 
 
< .001 
 
 
 
 
 
 
< .001 
 
 
 
 
     Severe Cognitive Impairment 
Dyspnea 
Depression 
Pain 
397 (19.5%) 
872 (42.7%) 
181 (8.9%) 
521 (25.5%) 
81 (4.3%) 
894 (47.9%) 
138 (7.4%) 
708 (38%) 
 
.001 
.093 
< .001 
    
 
 
!
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Table 4.  Unadjusted Odds Ratios and 95% Confidence Intervals for Variables Predicting 
Cancer Hospice Diagnosis (vs. Non-Cancer Hospice Diagnosis), n = 3905 
 
Variable  Odds Ratio 95% CI 
   
Sex 
     Male 
     Female 
 
1 
0.625* 
 
 
(0.550, 0.709) 
Age 
     18-34 
     35-64 
     65-74 
     75-84 
     85+ 
 
1 
0.855 
0.348 
0.226* 
0.072* 
 
 
(0.240, 3.042) 
(0.098, 1.234) 
(0.064, 0.797) 
(0.020, 0.256) 
Race 
     White 
     African American 
 
1.345* 
0.753* 
  
(1.072, 1.688) 
(0.584, 0.971) 
Primary Payment Source 
     No Charge/Other 
     Self-pay 
     Private Insurance 
     Other Government 
     Medicaid 
     Medicare 
Deceased 
 
1 
1.173 
3.246* 
1.994 
1.273 
0.337* 
2.565* 
 
 
(0.470, 2.931) 
(1.809, 5.824) 
(0.917, 4.336) 
(0.698, 2.319) 
(0.206, 0.551) 
(2.161, 3.044) 
Location Hospice Initiated 
     Agency Inpatient/Residential Facility 
     Private Residence 
     Residential Care Facility 
     Nursing Home 
     Hospital 
     Other 
Length of Stay in Days 
     180+ 
     90-179 
     30-89 
     8-29 
     < 7 
Number of ADL’s Requiring Help 
     0 
     1 
     2 
     3 
     4 
     5 
Cognitive Function at Admission 
     No Cognitive Impairment 
     Requires Occasional Reminders 
     Requires Situational Assistance 
     Requires Routine Assistance3 
     Severe Cognitive Impairment 
Dyspnea 
Pain 
 
 
1 
1.915* 
0.313* 
0.425* 
1.215 
1.389 
 
1 
2.013* 
3.406* 
4.238* 
2.885* 
 
1 
0.877 
0.366* 
0.298* 
0.315* 
0.284* 
 
1 
0.582* 
0.413* 
0.201* 
0.095* 
1.233* 
1.784* 
 
 
(1.400, 2.619) 
(0.196, 0.500) 
(0.301, 0.601) 
(0.814, 1.814) 
(0.608, 3.173) 
 
 
(1.507, 2.690) 
(2.666, 4.351) 
(3.345, 5.370) 
(2.271, 3.666) 
 
 
(0.598, 1.286) 
(0.271, 0.493) 
(0.230, 0.388) 
(0.246, 0.405) 
(0.220, 0.366) 
 
 
(0.477, 0.711) 
(0.340, 0.501) 
(0.167, 0.242) 
(0.073, 0.124) 
(1.087, 1.399) 
(1.556, 2.045) !
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Table 5.  Adjusted Odds Ratios and 95% Confidence Intervals for Variables Predicting 
Cancer Hospice Diagnosis (vs. Non-Cancer Hospice Diagnosis), n = 3905 
 
Variable Odds Ratio 95% CI 
   
Sex 
     Male 
     Female 
 
1 
0.920 
 
 
(0.787, 1.074) 
Age 
     18-34 
     35-64 
     65-74 
     75-84 
     85+ 
 
1 
0.994 
0.778 
0.671 
0.254* 
 
 
(0.263, 3.764) 
(0.203, 2.990) 
(0.175, 2.574) 
(0.066, 0.976) 
Race 
     White 
     African American 
 
1.664 
1.273 
  
(0.930, 2.975) 
(0.667, 2.430) 
Primary Payment Source 
     No Charge/Other 
     Self-pay 
     Private Insurance 
     Other Government 
     Medicaid 
     Medicare 
Deceased 
 
1 
1.161 
2.458* 
2.121 
1.426 
0.716 
3.041* 
 
 
(0.408, 3.309) 
(1.268, 4.765) 
(0.874, 5.148) 
(0.718, 2.832) 
(0.403, 1.272) 
(2.440, 3.790) 
Location Hospice Initiated 
     Agency Inpatient/Residential Facility 
     Private Residence 
     Residential Care Facility 
     Nursing Home 
     Hospital 
     Other 
Length of Stay in Days 
     180+ 
     90-179 
     30-89 
     8-29 
     < 7 
Number of ADL’s Requiring Help 
     0 
     1 
     2 
     3 
     4 
     5 
Cognitive Function at Admission 
     No Cognitive Impairment 
     Requires Occasional Reminders 
     Requires Situational Assistance 
     Requires Routine Assistance 
     Severe Cognitive Impairment 
Dyspnea 
Pain 
 
 
1 
1.806* 
0.655 
0.846 
1.302 
1.025 
 
1 
1.622* 
2.347* 
3.043* 
2.881* 
 
1 
0.972 
0.541* 
0.471* 
0.499* 
0.547* 
 
1 
0.725* 
0.569* 
0.305* 
0.148* 
0.855 
1.583* 
 
 
(1.243, 2.625) 
(0.384, 1.118) 
(0.564, 1.269) 
(0.817, 2.074) 
(0.375, 2.802) 
 
 
(1.151, 2.286) 
(1.755, 3.138) 
(2.296, 4.033) 
(2.147, 3.867) 
 
 
(0.624, 1.513) 
(0.376, 0.779) 
(0.339, 0.655) 
(0.365, 0.680) 
(0.396, 0.755) 
 
 
(0.576, 0.912) 
(0.454, 0.713) 
(0.244, 0.381) 
(0.108, 0.201) 
(0.731, 1.002) 
(1.338, 1.872) !  
